Our vision is to be the accepted PAIONeer in sedation and anesthesia; helping advance patient care.
PAION announces restructuring
PAION receives second milestone payment of three million USD from Ono Pharmaceutical through Start of Japanese Phase II with Remimazolam
Some of them are essential and required for running the website. Others improve your user experience and may be activated or deactivated at your discretion.